Papers

Peer-reviewed literature with structured metadata.

Trials

Interventional and observational studies by status and phase.

Topics

Key themes across evidence, policy, and outcomes.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across policy and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

News

Announcements, funding, and regulatory movement.

Research recaps

Weekly evidence summaries with key takeaways.

Map of research

Landscape views of compounds, trials, and outcomes.

Clinical research

Clinical pipeline tracking by indication and sponsor.

Podcast

Conversations with investigators and policy leaders.

Newsletter

Updates on trials, funding, policy, and new papers.

Guides

Practical explainers on methodology and safety.

Pricing

Clinical Outcome Measures

The validated psychometric tools, scales, and questionnaires utilized to gauge efficacy and safety in psychedelic medicine.

BDI-II

Scale/Measure

CAPS-4

Scale/Measure

CAPS-5

Scale/Measure

DES-II

Scale/Measure

GAF

Scale/Measure

IES-R

Scale/Measure

MADRS

Scale/Measure

PDS

Scale/Measure

PRISE

Scale/Measure

PSQI

Scale/Measure

PTGI

Scale/Measure

QIDS-SR

Scale/Measure

SDS

Scale/Measure

Research you can trust, with privacy and clarity built in.

Company

  • About
  • Contact
  • Newsletter
  • Access Program

Product

  • Feedback
  • Roadmap
  • Changelog

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.